BX Swiss TOP 30 CHF
1.379,27
PKT
+15,29
PKT
+1,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.02.24 | Roche Neutral | UBS AG | |
| 03.02.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 02.02.24 | Roche Kaufen | DZ BANK | |
| 02.02.24 | Roche Equal Weight | Barclays Capital | |
| 02.02.24 | Roche Sell | Deutsche Bank AG | |
| 02.02.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.02.24 | Novartis Buy | Deutsche Bank AG | |
| 01.02.24 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 01.02.24 | Roche Neutral | UBS AG | |
| 01.02.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 01.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 01.02.24 | Roche Hold | Jefferies & Company Inc. | |
| 01.02.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 31.01.24 | Roche Neutral | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 30.01.24 | Roche Sell | Deutsche Bank AG | |
| 30.01.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 29.01.24 | Holcim Kaufen | DZ BANK | |
| 29.01.24 | Givaudan Underweight | Barclays Capital | |
| 26.01.24 | Givaudan Hold | Deutsche Bank AG | |
| 26.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 26.01.24 | Swiss Re Equal Weight | Barclays Capital | |
| 26.01.24 | Givaudan Sell | UBS AG | |
| 26.01.24 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 25.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 25.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 25.01.24 | Givaudan Sell | UBS AG | |
| 25.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 24.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 22.01.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 22.01.24 | Richemont Buy | Deutsche Bank AG | |
| 22.01.24 | Roche Hold | Deutsche Bank AG |